Table 2

Environmental Exposure and Leptospirosis, Peru

Michael A.S. Johnson*†, Hannah Smith†, Priya Joseph†, Robert H. Gilman*†, Christian T. Bautista*‡, Kalina J. Campos*§, Michelle Cespedes†, Peter Klatsky†, Carlos Vidal¶, Hilja Terry†, Maritza M. Calderon*§, Carlos Coral†, Lilia Cabrera†, Paminder S. Parmar†, and Joseph M. Vinetz#

Author affiliations: *Asociación Benéfica Prisma, Lima, Peru; †Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; ‡U.S. Naval Medical Center Research Detachment, Lima, Peru; §Universidad Peruana Cayetano Heredia, Lima, Peru; ¶Ministry of Health, Iquitos, Peru; #University of California San Diego School of Medicine, La Jolla, California, USA

Main Article

Leptospirosis seroprevalence among residents by study site

	Pampas San Juan % (pos/total)^a	Rural communities^b % (pos/total)	Belen % (pos/total)	Comparison among all sites	Comparison of Belen vs. rural community
Overall^c	0.7 (1/150)	16.5 (52/316)	28.0 (182/650)	p < 0.001	p < 0.001
Sex
F	0.0 (0/57)	15.8 (24/152)	29.6 (105/356)	p < 0.001	p = 0.001
M	1.1 (1/93)	17.1 (28/164)	26.4 (77/292)	p < 0.001	p = 0.024
M vs. F comparison	p = 0.999	p = 0.758	p = 0.428
^aLeptospirosis prevalence (number of positive cases/total of persons tested). ^bSan Carlos, Moralillo, and Buen Pastor. ^cOptical density >0.500.

Main Article

Page created: February 22, 2011

Page updated: February 22, 2011

Page reviewed: February 22, 2011

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.